Elisa Gotti

Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy

M. Introna, A. Rambaldi, Alessandro Rambaldi, 2013, The Journal of Immunology.